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P glycoprotein-mediated cholesterol cycling determines proxi- mately 20% of the total lipid content [1]. It assumes an
mal tubular cell viability. asymmetric intramembrane distribution, forming “deter-
Background. MDR P glycoproteins may help transport plasma gent resistant microdomains” (DRMs) via hydrophobicmembrane free cholesterol (FC) to the endoplasmic reticulum
interactions with resident membrane glyco/sphingolipids(ER), where it undergoes acylation, forming cholesterol esters
[2, 3]. DRMs can be incorporated into larger structures,(CE). This study assessed whether P glycoprotein inhibitors alter
renal tubular FC/CE expression, thereby altering cell integrity. such as membrane “rafts” and “caveolae” [4–8]. The
Methods. Mouse proximal tubule segments (PTS) were ex- functional significance of the latter is suggested, in part,
posed to chemically dissimilar P glycoprotein inhibitors [proges-
by the fact that these structures concentrate a host ofterone (prog), trifluoperazine (TFP), or cyclosporine A (CsA)].
critical signaling molecules [4–8]. These relatively newTheir effects on FC/CE and adenosine 5-triphosphate (ATP)
levels, phospholipid expression, lipid peroxidation, and cell insights have changed the view of cholesterol as simply
viability (lactate dehydrogenase release; LDH) were assessed. being a membrane “building block,” which decreases
P glycoprotein inhibitor effects on cultured proximal tubular membrane fluidity [9], to a molecule that can exert com-(HK-2) cell viability and susceptibility to Fe-induced oxidant
plex effects on overall cell homeostasis.stress were also addressed.
Results. When applied to PTS, prog, TFP, and, to lesser Although approximately 90% of cholesterol is local-
extent, CsA induced dose-dependent ATP reductions (90%), ized to the plasma membrane, it is not a static membrane
CE decrements (40%), and LDH release (60%). No con- constituent. Rather, it impacts, and participates in, mem-
comitant changes in lipid peroxidation or phospholipid profiles
brane cycling [10–13]. Cholesterol can exit the plasmawere observed. Ouabain did not preserve tubular ATP, suggesting
membrane and traffic to the endoplasmic reticulum (ER),that decreased ATP production, rather than increased consump-
tion, was operative. Mechanisms leading to cell lysis were not a process that may be mediated, or facilitated, by “multi-
identical, as glycine and arachidonic acid blocked prog- but drug resistance” (MDR) P glycoproteins [10, 14–16].
not TFP-mediated cell death. When prog-driven CE reductions
Upon gaining access to the ER, acyl-CoA:acyltransfer-were attenuated in PTS with a procycling agent (cholesterol
ase (ACAT) converts free cholesterol (FC) into choles-oxidase), decreased cell death resulted. P glycoprotein inhibi-
tors also caused dose-dependent HK-2 cell death. Blocking Fe- terol esters (CE). The latter can be hydrolyzed back to
mediated CE formation (10) with sublethal CsA doses led FC by esterases within either the cytosol or the lysosomal
to a marked increase in Fe-mediated cell death. system [10]. The regenerated FC can then reach otherConclusions. P glycoproteins may be critical to tubule cho-
subcellular structures, for example, mitochondria, or belesterol transport. If blocked with pharmacologic agents, de-
recycled back to the plasma membrane. The latter pro-creased ATP production, overt cell lysis, and/or a marked pro-
pensity to superimposed tubular cell injury can result. cess completes the so-called cholesterol/cholesterol ester
cycle [17, 18].
Several pieces of evidence gathered in this laboratory
Cholesterol is a critical component of plasma mem- have suggested that changes in total cholesterol content,
branes, and in proximal tubules it represents approxi- and/or its relative distribution between FC and CE pools,
are perturbed during and/or after acute renal tubular
damage: First, it has recently been demonstrated thatKey words: progesterone, cyclosporine A, trifluoroperazine, ATP
depletion, cholesterol esters. during 30 to 45 minutes of in vivo ischemia, a marked
increase in CE, but not FC, results [19]. This implies that
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renal failure (for example, 18 to 24 hours following renal recovered by centrifugation through 32% Percoll (Phar-
macia, Piscataway, NJ, USA). After multiple washingsischemia, glycerol-induced rhabdomyolysis, or urinary
tract obstruction), an approximate 20 to 30% increase in iced buffer, the PTS were suspended (2 to 4 mg
PTS protein/mL) in experimentation buffer (in mmol/L:in total renal cortical/proximal tubule cholesterol content
develops [1]. This affects both the FC and CE pools NaCl, 100; KCl, 2.1; NaHCO3, 25; KH2PO4, 2.4; MgSO4,
1.2; MgCl2, 1.2; CaCl2, 1.2; glucose, 5; alanine, 1; Naand is mediated, at least in part, by increased de novo
(mevalonate pathway) cholesterol synthesis [20]. Since lactate, 4; Na butyrate, 10; 36 kD dextran, 0.6%) and
gassed with 95% O2/5% CO2 (final pH, 7.4). They werethis pathway is critical to the production of steroids,
ubiquinone, and isoprenoids, and not simply cholesterol, rewarmed to 37C in a heated shaking water bath over
15 minutes, and then each PTS preparation was equallyits up-regulation could exert protean effects on postin-
jury cell homeostasis. Third, cholesterol accumulation divided, usually into four aliquots (1.25 mL of PTS sus-
pension placed into 10 mL Erlenmeyer flasks). Theyduring the maintenance phase of acute renal failure can
contribute to the so-called state of “acquired cytoresis- were then ready for use in individual experiments, as
described later in this article.tance” [1]. This is indicated by observations that blocking
post-injury cholesterol synthesis [20] or reducing its con- Progesterone effects on tubule FC/CE levels and cell
viability. Eight sets of PTS, prepared as noted previouslytent by chemical extraction [1] abrogates this cytoresis-
tant state. Fourth, this laboratory has demonstrated that in this article, were divided into four aliquots: (1) control
incubation, (2) incubation with progesterone (100 g/mL;if either FC or CE is reduced in normal tubular cells by
application of cholesterol oxidase or cholesterol esterase Sigma, St. Louis, MO, USA; P-0130), (3) incubation with
progesterone in the presence of 0.5 U/mL cholesteroltreatment, respectively, profound adenosine 5-triphos-
phate (ATP) depletion, followed by tubular cell death, oxidase (COase; Sigma C-7149), and (4) incubation with
COase alone. Note that COase increases cholesterol cy-results [21]. This underscores that maintenance of both
FC and CE pools is critical to tubular cell integrity. cling, resulting in striking increases in cholesterol ester
levels [19]. Thus, the progesterone/COase experimentAlthough these studies have documented that changes
in cholesterol homeostasis are both concomitants and was added, in part, as a positive control, that is, to prove
that progesterone can block cholesterol ester formationdeterminants of acute tubular damage, the importance
of possible P glycoprotein-mediated cholesterol cycling under conditions that normally increase cholesterol cy-
cling. The progesterone used in these experiments wason tubular cell integrity has not been previously defined.
This would seem an important issue, both in light of the solubilized in dimethyl sulfoxide (DMSO; final concen-
tration, 1%; added to all aliquots to control for possiblepreviously mentioned observations and because at least
some MDR P glycoprotein inhibitors (for example, cyclo- independent DMSO effects). After completing 30-minute
incubations, 150 L tubule suspension samples were re-sporine A, Tacrolimus) can either cause or predispose
to acute renal failure. Therefore, this study has addressed moved from each flask for determination of lethal cell
injury, as determined by LDH release [22]. The bulk ofwhether interruption of the P glycoprotein cholesterol
transport pathway, using three chemically dissimilar P the remaining tubule aliquots (800 L) were placed into
3 mL of chloroform:methanol (1:2), vortexed, and sub-glycoprotein inhibitors [progesterone, trifluoperazine,
cyclosporine A (CsA)], impacts tubular cell integrity and jected to lipid extraction as previously described [19–21].
Following lipid recovery, the samples were subjected toresponsiveness to superimposed attack.
gas chromatographic (GC) analysis to determine the FC
and CE content [19, 20].
METHODS
Impact of progesterone on tubule adenine nucleotide
Isolated mouse proximal tubule segment experiments profiles. It has previously been determined that treatment
of tubules with cholesterol esterase (CEase) causes pro-Proximal tubule isolation and preparation. Female CD-1
mice, weighing 25 to 35 g (Charles River Laboratories, found tubular ATP depletion [21]. The following experi-
ment was undertaken to ascertain whether interruptionWilmington, MA, USA) and maintained under normal
vivarium conditions, were used for all isolated tubule of normal FC/CE cycling with progesterone has the same
effect.experiments. The mice were anesthetized with pentobar-
bital (2 mg IP). The kidneys were immediately re- Fifteen-minute experiments. Four sets of tubules were
each divided into four aliquots: control incubation (withmoved through a midline abdominal incision. The corti-
ces were recovered by dissection with a razor blade on 1% DMSO) and incubation with 25, 50 or 100 g/mL
progesterone in DMSO. After completing 15-minute in-an iced plate, and proximal tubule segments (PTS) were
isolated as previously described [22]. In brief, the cortical cubations, an aliquot was removed to determine % lac-
tate dehydrogenase (LDH) release. Trichloroacetic acidtissues were minced with a razor blade, digested with
collagenase, passed through a stainless steel sieve, and was immediately added to the remainder of each aliquot
(6.66% final concentration). The adenine nucleotides werethen pelleted by centrifugation (4C). Viable PTS were
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extracted and quantified by high pressure liquid chroma- phospholipid expression. To this end, six sets of tubules
tography (HPLC), as previously described [23]. ATP were divided into four aliquots: (1) control incubation (with
results were expressed as nmol/mg protein and as ATP/ 1% DMSO), (2) 100 g/mL progesterone, (3) 250 g/mL
adenosine diphosphate (ADP) ratios. TFP, and (4) a second control incubation. After complet-
Thirty-minute experiments. The above experiment was ing 30-minute incubations, the percent of LDH release
repeated exactly as described except that the incubations was determined. The phospholipids were extracted in
were conducted for 30 minutes rather than 15 minutes. chloroform:methanol, and then individual plasma mem-
Effect of Na,K-ATPase inhibition of progesterone- brane phospholipids were separated by two-dimensional
mediated ATP decrements. The following experiment was gel thin layer chromatography (TLC) [27]. Individual
undertaken to ascertain whether progesterone-mediated phospholipids were quantified by scraping each corre-
ATP decrements were a secondary consequence of in- sponding TLC spot from the silica plates and then de-
creased Na,K-ATPase-mediated ATP consumption. To termining its phosphate content [27]. The results were
this end, three PTS preparations were each divided into expressed as both absolute amounts and as the percent
four aliquots: (1) control incubation, (2) incubation with to which each recovered phospholipid contributed to the
50 g/mL progesterone, (3) incubation with ouabain total recovered phospholipid mass (the sum of phospha-
(1 mmol/L; solubilized in DMSO, final concentration, 1%), tidyl-choline, -serine, -inositol, -ethanolamine and sphin-
and (4) incubation with progesterone  ouabain. After gomyelin). In addition, lysophospholipid formation was
completing 30-minute incubations, % LDH release and sought [27].
adenine nucleotide profiles were determined, as noted
previously in this article. Effect of progesterone and TFP on tubular cell
lipid peroxidation
Influence of trifluoperazine on FC/CE levels
Since alterations in mitochondrial performance can beand cell viability
associated with increments or decrements in free radical
The following sets of experiments were undertaken to production, the following experiment ascertained whether
address whether inhibition of cholesterol cycling with progesterone or TFP alter the extent of tubule lipid per-
trifluoperazine (TFP), a second P glycoprotein inhibitor oxidation. To this end, four sets of tubules were each
that is chemically unrelated to progesterone [24–26], also divided into four aliquots: (1) control incubation (in the
impacts tubular cell viability. To this end, four sets of presence of 1% DMSO, the progesterone/TFP vehicle),
PTS were prepared and each was divided into two ali- (2) 100g/mL progesterone, (3) a second control incuba-
quots: (1) control incubation (in the presence of TFP
tion, and (4) incubation with 250 g/mL TFP. After 30-carrier) and (2) TFP, 250g/mL (in DMSO, final concen-
minute incubations, the percent of LDH release wastration, 1%). After completing 30-minute incubations,
determined and then lipid peroxidation was gauged bythe percent of LDH release and FC/CE content were
determining malondialdehyde (MDA) concentrationsdetermined.
(nmol/mg tubule protein) [28].
Impact of TFP on adenine nucleotide pools
Effect of glycine on progesterone and TFP-mediated
Dose response curve. Four sets of tubules were each cell death
divided into four aliquots: control incubation and 250,
The following experiment assessed whether glycine,125, and 62.5 g/mL TFP. The control tubules were incu-
which is known to block ATP depletion-mediated cellbated in the presence of 1% DMSO (the concentration
lysis [29], can attenuate either progesterone or TFP cyto-used for the 250 g/mL TFP challenge). After 15-minute
toxicity. Eight sets of tubules were each divided into fourincubations, the percent of LDH release and adenine
aliquots: (1) control incubation, (2) incubation with 2nucleotide profiles were assessed.
mmol/L glycine, (3) incubation with either 100 g/mLImpact of ouabain. To ascertain whether increased
progesterone or 250g /mL TFP, and (4) incubation withNa,K-ATPase activity contributed to ATP decrements
either progesterone or TFP  glycine (N  4 completeinduced by TFP, four sets of tubules were each divided
experiments with each test agent). After completing 60-into four aliquots: (1) control incubation, (2) incubation
minute incubations, protection was gauged by the per-with 125 g/mL TFP, (3) incubation with 1 mmol/L oua-
cent of LDH release. The potential impact of glycine onbain, and (4) combined incubation with TFP  ouabain.
adenine nucleotide concentrations was also assessed.After completing 15-minute incubations, the percent of
LDH release and adenylate profiles were assessed.
Effect of arachidonic acid on progesterone
and TFP cytotoxicityImpact of progesterone and TFP on tubule
phospholipid profiles Similar to glycine, arachidonic acid (C20:4) added to
isolated tubules mitigates ATP depletion-mediated cellThe following experiments assessed whether inhibi-
tion of cholesterol trafficking impacts plasma membrane death [30, 31]. Therefore, to gain complementary infor-
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mation to that gleaned from the above experiments, they [36], (5) 1 g/mL CsA  7.5 mol/L FeHQ, and (6)
5 g/mL CsA  7.5 mol/L FeHQ. After 18-hour incu-were repeated exactly as described with the following
exceptions: (1) 50mol/L C20:4 (in DMSO, final concen- bations, cell injury was assessed by the percent of LDH
release.tration, 1.25%) was substituted for glycine, (2) the incu-
bations were conducted for 30 minutes not 60 minutes, CsA effects on cholesterol/cholesterol ester levels.
Near-confluent flasks of HK-2 cells (N  16) wereand (3) evaluations were restricted to the percent of
LDH release. equally divided into four treatment groups: (1) control
incubation, (2) incubation with 5 g/mL CsA, (3) 7.5
Cyclosporine effects on tubule cholesterol and adenine mol/L FeHQ, and (4) 5 g/mL CsA FeHQ. After 18-
nucleotide expression hour incubations, the cells were harvested for cholesterol
analysis [20].Cyclosporine A, like progesterone and TFP, inhibits P
glycoprotein transport [32–34]. Therefore, the following Effect of P glycoprotein inhibition on ATP/ADP ratios
in HK-2 cells. Because HK-2 cells are supported by bothexperiment ascertained whether CsA can also lower tu-
bule CE levels and ATP. Four sets of tubules were incu- glycolytic and aerobic ATP production, both pathways
must be inhibited to lower ATP [36]. The following ex-bated for 30 minutes under one of the following condi-
tions: control incubation and incubation with either 25, periment tested whether P glycoprotein inhibition spe-
cifically suppresses aerobic ATP production or whether50, or 100 g/mL CsA (dissolved in ethanol; 1% final
concentration). One percent ethanol was also added to blockade of both aerobic and glycolytic pathways might
be involved. To this end, HK-2 cells were seeded in Tthe control incubation. After 30 minutes, the tubules
were analyzed for FC/CE content and percent of LDH 75 flasks and allowed to grow to near confluence (3 days).
The media were then changed and replaced with freshrelease. In a second series of four experiments, the incu-
bations were continued for 60 minutes, followed by as- media containing either 100 g/mL progesterone (in 1%
DMSO) or 1% DMSO alone (N  3 flasks each). Aftersessments of adenine nucleotides and percent of LDH
release. 30 minutes, trichloroacetic acid was added to the flasks
(6.66% final concentration). The cells were recovered by
HK-2 cell experiments detachment with a rubber policeman, and then adenine
nucleotide concentrations were determined as previouslyProgesterone, TFP, and CsA cytotoxicity in cultured
proximal tubule cells. The following experiments were described [23, 36]. The results were expressed as ATP/
ADP ratios.undertaken to confirm that the previously utilized P gly-
coprotein inhibitors can exert their cytotoxic effects in
Statisticsa second model system (HK-2 cells, an immortalized cell
line established from normal human kidney) [35]. The All values are presented as means 1 SEM. Statistical
comparisons were performed by the paired or unpairedcells were maintained under routine culture conditions
in T75 flasks with keratinocyte serum free medium [35]. Student t test. If multiple comparisons were made, the
Bonferroni correction was applied. FC and CE wereOn of the day of experimentation, flasks were trypsinized
and seeded into 24-well plates. Approximately eight expressed as nmol/mol inorganic phosphate (Pi).
hours later, the plates were divided into the following
treatment groups: (1) progesterone treatment—four
RESULTS
wells in each plate were incubated with either 0, 6.25,
Progesterone effects on FC/CE and cellular integrity12.5, or 50 g/mL progesterone; (2) TFP treatment—the
previously mentioned treatment was repeated, substitut- As depicted in Figure 1A, 100 g/mL progesterone
treatment caused a 37% reduction in CE levels. No sig-ing TFP in the above concentrations; and (3) CsA treat-
ment—CsA was tested as noted previously in the same nificant change in free cholesterol content was observed
(Fig. 1C). As previously observed [19], treatment of tu-concentrations. Four sets of plates were used for each
test agent, each conducted on two or more occasions. bules with cholesterol oxidase (COase) caused a dra-
matic increase in CE levels, rising 100 over controlAfter 18-hour incubations, cell injury was assessed by
the percent of LDH release [35]. values (due to FC liberation from the plasma membrane,
allowing it to traffic to the ER for esterification; Fig.Effect of CsA on the extent of superimposed oxidant
injury and cholesterol expression. Cell injury experiments. 1B, note the change in the y-axis scale). Progesterone
approximately halved this COase-induced CE incrementFour sets of 24-well plates were seeded with HK-2 cells.
After a 24-hour period, they were subjected to one of (Fig. 1B), validating its ability to attenuate FC trafficking.
The COase-mediated CE increments were associatedthe following six incubation conditions: (1) control incu-
bation, (2) 1 g/mL CsA, (3) 5 g/mL CsA, (4) an oxi- with a slight reduction in FC levels (P 	 0.001).
Figure 2 presents the extent of lethal cell injury in-dant challenge (7.5 mol/L ferrous ammonium sulfate,
complexed to 7.5 mol/L hydroxyquinoline; “FeHQ”) duced by the previously mentioned protocols. The pro-
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Fig. 1. Cholesterol ester (CE) and free cholesterol (FC) levels in proximal tubules treated with either progesterone (prog), cholesterol oxidase
(COase), or prog  COase. (A) Progesterone caused an approximate 40% reduction in CE compared with control tubules. (B) COase caused a
massive CE increase (42 vs. 3 for normal tubules; left hand panel; note difference in scales). Prog treatment markedly reduced COase-mediated
CE increments. This indicates that COase caused increased plasma membrane FC cycling to the ER, a process blocked by progesterone. (C) Prog
treatment did not substantially change FC content (to be expected because an approximate 1 nmol/mol decrease in CE would only lead to a 1
nmol/mol increase in FC, too small of an amount to be detected due to the relatively massive amount of the total FC mass (300 nmol/mol
Pi). However, given the dramatic CE increase with COase treatment (40 nmol/mol Pi), a reciprocal FC decrease was apparent (P 	 0.001).
Fig. 2. Percentage of lactate dehydrogenase
(LDH) release that corresponded to the FC/CE
changes observed in Figure 1. Progesterone
(Prog) caused marked cytotoxicity (in com-
parison to control tubules; P 	 0.01). In the
dosage used, cholesterol oxidase (COase)
caused no lethal cell injury. COase treatment
mitigated this progesterone toxicity (P	 0.01),
a finding that corresponded to its ability to
raise cholesterol ester content (Fig. 1B).
gesterone-mediated CE reductions corresponded with a one dose (Fig. 3B). As depicted in Figure 4, virtually
identical results were observed after 30-minute proges-significant increase in LDH release (rising from 12 to
34%, P 	 0.01). In the dose employed, COase did not, terone incubations.
by itself, induce LDH release. Rather, it significantly
Impact of ouabain on progesterone-mediated(P 	 0.01) attenuated progesterone-mediated LDH re-
cytotoxicity and ATP depletionlease, corresponding to its ability to increase CE concen-
trations (Fig. 1B). Ouabain (oua) failed to improve progesterone (50
g/mL)-mediated ATP/ADP decrements (Fig. 5A).
Progesterone effects on tubule adenylate profiles Whereas neither ouabain nor low-dose progesterone in-
dependently caused LDH release, a modest increase inAs depicted in Figure 3A, 15-minute incubations with
increasing doses of progesterone caused reciprocal dec- LDH release occurred with combined ouabain/proges-
terone treatment (Fig. 5B).rements in ATP/ADP ratios. At the highest test dose
(100 g/mL), this corresponded with a 95% decrease in
TFP effects on FC/CE expression and LDH releaseabsolute ATP content (from 10.1  0.3 to 0.6  0.1
nmol/mg protein). These ATP decrements preceded le- As in the case of progesterone, 250 g/mL TFP also
inhibited tubule cholesterol cycling, as reflected by sig-thal cell injury, given that no increase in LDH release
was observed with either the 25 or 50 g/mL progester- nificant CE declines (Fig. 6A) without a change in FC
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Fig. 3. Progesterone dose titration effects on
tubule ATP/ADP ratios and corresponding
LDH release after 15-minute incubations. (A)
Increasing doses of progesterone caused dra-
matic stepwise reductions in ATP/ADP ratios.
These reductions were observed prior to lethal
cell injury, since ATP/ADP reductions were
seen with the 25 and 50 g/mL progesterone
doses, which did not at the time cause increased
LDH release (B). At the 100 g/mL dose,
both profound ATP/ADP ratio depression
and increased LDH release were apparent.
Fig. 4. Progesterone dose titration effects on
tubule ATP/ADP ratios (A) and correspond-
ing LDH (B) release after 30-minute incuba-
tions. These experiments were identical to
those depicted in Figure 3, with the exception
that assessments were made after a 30-minute
rather than a 15-minute incubation. The re-
sults obtained essentially mimicked those de-
scribed for the Figure 3 experiment.
Fig. 5. Evaluation of the impact of Na,K-
ATPase inhibition (ouabain) on progesterone-
mediated ATP declines and cytotoxicity. Oua-
bain (Oua) slightly worsened, rather than pro-
tected against the ATP/ADP declines evoked
by progesterone (Prog) treatment, indicating
that the ATP reductions were not due to in-
creased Na,K-ATPase activity (A). Similarly,
ouabain tended to worsen rather than mitigate
the extent of progesterone-mediated LDH re-
lease (B).
concentrations (Fig. 6B). Corresponding with the CE 0.07 nmol/mg protein; at the highest test TFP concentra-
tion). These changes were observed in the absence ofdecrements was a dramatic increase in the percent of
LDH release (Fig. 6C). lethal cell injury, given that marked ATP/ADP reduc-
tions were observed with relatively low TFP doses (125
TFP effects on cellular energetics g/mL) in the absence of increased LDH release (Fig.
7B). As with progesterone, TFP-mediated ATP/ADPTrifluoperazine, like progesterone, caused dramatic,
dose-dependent declines in ATP/ADP ratios (Fig. 7A) reductions were not attenuated by concomitant ouabain
treatment (Fig. 8).and in absolute ATP content (from 8.8  0.7 to 0.45 
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Fig. 6. Evaluation of trifluoperazine (TFP)
effects on isolated tubule cholesterol esters,
free cholesterol, and cellular injury. TFP (250
g/mL) reproduced progesterone’s effects on
tubule cholesterol expression, lowering choles-
terol (chol) esters (A) without impacting free
cholesterol content (B). TFP also induced
marked cytotoxicity, as gauged by 45% LDH
release (C).
Fig. 7. Trifluoperazine (TFP) dose titration
effects on tubule ATP/ADP ratios and corre-
sponding LDH release after 15-minute incu-
bations. As with the progesterone incubations
depicted in Figure 3, TFP caused dose-depen-
dent reductions in ATP/ADP ratios that pre-
ceded the onset of lethal cell injury, as gauged
by LDH release (seen with the 62.5 and 125
g/mL concentrations).
Fig. 8. Impact of Na,K-ATPase inhibition
(ouabain) on trifluoperazine (TFP)-mediated
ATP declines and cytotoxicity. Ouabain (Oua)
failed to mitigate TFP induced ATP/ADP de-
clines, indicating that the ATP reductions were
not due to increased Na,K-ATPase activity
(A). Ouabain also failed to mitigate TFP-medi-
ated LDH release (B).
Tubular phospholipid profiles under conditions of lipid generation was observed [27], despite the fact that
progesterone or TFP exposure lethal cell injury was induced.
Despite the fact that both progesterone and TFP de-
Effect of progesterone and TFP on tubular cellcreased CE expression, there were no associated alter-
lipid peroxidationations in either absolute (data not shown) or in relative
Both progesterone and TFP induced cytotoxicity (53phospholipid content (Table 1). This was despite the fact
10%, 30  4% vs. their respective controls, 12  2%;that both agents caused lethal cell injury, as reflected
P 	 0.04). This toxicity was dissociated from apparentby LDH release (controls, 14  1%; TFP, 51  6%;
progesterone, 36  4%). Additionally, no lysophospho- oxidative stress, as MDA levels tended to fall, not rise,
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Table 1. Phospholipid profiles in isolated tubules under control dependent cytotoxicity. TFP was by far the most toxic
conditions and following progesterone and
at each concentration tested. Progesterone and CsA hadtrifluoperazine (TFP) treatment
comparable toxicity, but the latter expressed relatively
Group % SM % PC % PE % PS % PI greater toxicity at the lower test concentrations.
Controls 13.30.9 44.70.8 27.51.4 7.10.2 7.40.2 CsA effects on superimposed Fe-mediated HK-2 cell
Progesterone 12.30.2 44.90.3 27.80.6 7.30.4 7.80.2
injury. Neither CsA test dose (1 or 5 g/mL) causedTFP 14.20.8 45.21.8 25.90.6 6.80.5 7.90.3
P NS NS NS NS NS increased LDH release (Fig. 14A). However, both CsA
doses increased Fe-mediated cytotoxicity, as reflected byIsolated tubules were treated with either progesterone (100 g/mL) or TFP
(250 g/mL) for 30 minutes and then their phospholipid profiles were assessed. significant increases in LDH release.
The results were compared to those observed in control incubated tubules. The
CsA effects on cholesterol ester/free cholesterol expres-results are presented as % to which each phospholipid contributed to the total
recovered phospholipid mass, defined as the sum of SM  PC  PE  PS  PI sion. As shown in Figure 15, CE levels in normal HK-2
(sphingomyelin, phosphidyl-choline, -ethanolamine, -serine, and -inositol, re-
cells were 1.66  0.03 nmol/mol phosphate. CsA treat-spectively). No significant differences in their relative amounts, or in their abso-
lute amounts (data not shown) were observed, compared with control tubules. ment reduced these levels by 40% (P 	 0.005). The
Fe challenge induced an approximate tenfold increase
in CEs, as previously noted [20]. Concomitant CsA treat-
ment (5g/mL) almost completely blocked this Fe-medi-with either treatment (controls, 1.03 0.2; progesterone,
ated CE increment.0.8  0.2; TFP, 0.8  0.1; nmol/mg protein; all P  NS).
Free cholesterol levels were unaffected by CsA treat-
ment (326  10, 325  8; with 0, 5 g/mL CsA, respec-Glycine effects on progesterone and TFP cytotoxicity
tively). The Fe challenge lowered free cholesterol toAs shown in Figure 9A, glycine (gly) completely blocked
237  10. This result was not statistically affected byprogesterone-mediated LDH release. This protective ef-
concomitant CsA treatment (248  7 g/mL).
fect was completely dissociated from any improvement
If these results are presented as the percentage to
in progesterone-mediated ATP depletion (Fig. 9B). In
which cholesterol esters contributed to the total choles-
stark contrast to its protective effect against progester-
terol (FC  CE) content, CsA caused dramatic reduc-
one cytotoxicity, glycine did not block TFP’s cytotoxicity
tions in relative CE expression, indicative of interruption
(Fig. 10). Again, glycine did not impact TFP’s ability to
of cholesterol/cholesterol ester cycling (controls, 0.58 
deplete tubule ATP concentrations.
0.08%, CsA, 0.38  0.08% P 	 0.001; Fe 6.8  1.1%,
Fe  CsA, 0.8  0.6%, P 	 0.015).C20:4 effects on progesterone and TFP cytotoxicity.
Arachidonic acid (C20:4) recapitulated glycine’s effect ATP/ADP ratios in HK-2 cells in response to
in that it conferred significant—albeit incomplete—protec- progesterone treatment
tion against progesterone cytotoxicity (Fig. 11A) but not Control cells had ATP/ADP ratios of 13.1  0.2. Only
TFP cytotoxicity (Fig. 11B). a very slight and nonsignificant reduction in ATP/ADP
ratios was observed with progesterone treatment (11.5 CsA effects on tubule cholesterol and adenine
0.6). This is consistent with the concept that progester-nucleotide profiles
one/P glycoprotein inhibition suppresses mitochondrial,
The 30-minute CsA exposure caused only very mod- but not anaerobic, ATP production (based on the facts
est, but dose-dependent, decrements in proximal tubular that progesterone profoundly lowers ATP in strict aero-
CE levels (Fig. 12A) without any discernible change in bic cell, that is, isolated tubules, but does not suppress
FC (data not shown). The CE decrements were associ- ATP in cells that have both glycolytic as well as aerobic
ated with only slight, dose-dependent increments in energy production pathways) [36].
LDH release (8  2%; 8  2%; 10  3%; 11  3% with
0, 25, 50, and 100 g/mL CsA, respectively; P 	 0.03, 0
DISCUSSIONvs. 100 g/mL CsA).
After 60-minute incubations, modest, dose-depen- The results of the present study provide compelling
dent, decrements in ATP/ADP ratios were apparent with evidence for the concept that normal cholesterol–choles-
CsA treatment (Fig. 12B). This corresponded with 13  terol ester cycling is essential to tubular cell viability.
1%, 13  1%, 14  1%, and 16  2% LDH release This is based on observations that treatment of isolated
with 0, 25, 50 and 100 g/mL CsA respectively (P 	 tubules with progesterone or TFP, two chemically dis-
0.015, 0 vs. 100 g/mL CsA). similar inhibitors of P glycoprotein-mediated plasma
membrane cholesterol transport, culminated in approxi-
HK-2 cell experiments mately 35% CE reductions, severe ATP depletion, and
Progesterone, TFP, and CsA toxicity experiments. As ultimately tubular cell death. CsA, a third P glycoprotein
inhibitor, exerted the same qualitative effects as proges-shown in Figure 13, each of these agents caused dose-
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Fig. 9. Assessment of glycine (Gly) as a cyto-
protectant against progesterone toxicity. Ad-
dition of 2 mmol/L glycine completing blocked
progesterone-mediated LDH release (A) with-
out exerting any effect on progesterone-medi-
ated ATP depletion (B). Symbols are: ( ) no
progesterone; () progesterone; 0, no glycine
treatment.
Fig. 10. Assessment of glycine (Gly) as a cyto-
protectant against trifluoperazine (TFP) toxic-
ity. Unlike the results depicted in Figure 9, 2
mmol/L glycine had no cytoprotective effect
against TFP-mediated LDH release (A). It
also failed to preserve ATP content (B). Sym-
bols are: ( ) no TFP; () TFP.
Fig. 11. Assessment of arachidonic acid (C20:4)
as a cytoprotectant against progesterone and
trifluoperazine (TFP) toxicity. C20:4 mitigated
progesterone, but not TFP-mediated LDH re-
lease (A and B, respectively). In the absence
of either P glycoprotein inhibitor, C20:4 ex-
erted no independent effect on LDH release.
terone and TFP, but to a much less severe degree. The membrane→ ER movement [24, 32] implies that identi-
cal results with each need not be expected.reason for this quantitative difference is unknown. How-
ever, given that these agents can differentially impact Because MDR P glycoproteins function as cellular
efflux pumps and membrane phospholipid “flippases”intracellular cholesterol distribution and not just plasma
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Fig. 12. Cyclosporine A (CsA) effects on iso-
lated tubule cholesterol ester (CE) levels and
ATP/ADP ratios. (A) Increasing doses of CsA
induced slight, but statistically significant, dose-
dependent declines in CE levels (P 	 0.035 at
100 g/mL; 30-min incubations). Modest dose-
dependent ATP/ADP declines were also ap-
parent (B; assessed after 60-min incubations).
Fig. 15. Cyclosporine A’s effect on Fe-mediated cholesterol ester in-
crements in HK-2 cells. CsA (5 g/mL) induced an approximate 40%
reduction in cholesterol ester (CE) levels in the absence of an Fe
challenge ( ). That Fe challenge caused an approximate tenfold in-Fig. 13. Effects of progesterone (), trfluoperazine (TFP; ), and
crease in CE levels. This change was almost completely blocked bycyclosporine A (CsA; ) on HK-2 cell viability after 18-hour incuba-
concomitant CsA treatment ().tions. Each of the three test agents induced dose dependent HK-2 cell
death, as assessed by % LDH release.
[37, 38], it could be argued that the above-noted toxicity
resulted from these action(s), rather than from altered
cholesterol cycling, per se. Furthermore, one might ques-
tion whether severe ATP depletion might have been the
cause of the observed CE reductions, rather than vice
versa. However, previous data from this laboratory argue
against these possibilities. When CEs were directly re-
duced in isolated tubules by membrane-impermeant cho-
lesterol esterase treatment, ATP depletion, followed by
lethal cell injury, resulted [21]. That comparable patterns
and degrees of cell injury were produced in this study by
progesterone and TFP provide additional data to support
the concept that CE reductions, per se, can trigger ATP
depletion, tubular injury, and ultimately cell death.
The mechanism by which progesterone, TFP, and to a
lesser extent CsA, induced dose-dependent ATP depletionFig. 14. Effect of CsA on Fe-mediated HK-2 cell death. In the doses
employed, CsA had no independent effect on HK-2 cell viability. How- remains unknown. One possibility that was considered is
ever, each dose of CSA caused highly significant increases in Fe-mediated that altered plasma membrane cholesterol homeostasis
LDH release. This corresponded with CsA’s ability to block an approxi-
might increase Na influx, thereby driving Na,K-ATPasemate tenfold increase in Fe-mediated CE increments (Fig. 15). Symbols
are: ( ) no Fe; () Fe. activity, and thus, decrease ATP content. Such a scenerio
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would be analogous to that which develops with Na iono- ments ultimately produce plasma membrane disruption
remain to be defined.phore treatment (for example, with nystatin or ampho-
Because proximal tubules sustain some degree of iso-tericin B) [30]. However, in the latter situation, ouabain
lation injury that can potentially impact results [21], ex-preserves tubular ATP content [30]; conversely, in the
periments were also performed with cultured HK-2 cells.case of progesterone and TFP, ouabain had no ATP-
These were done to (1) confirm that P glycoprotein inhi-sparing effect. This implies that decreased mitochondrial
bition can, in fact, induce lethal tubular cell injury, andATP production, rather than increased ATP utilization,
(2) make this determination with lower inhibitor concen-was more likely responsible. A second possible explana-
trations, applied over a longer time period. Each test agenttion for the ATP depletion is that it was simply a second-
induced striking dose-dependent cytotoxicity. Addition-ary consequence of lethal tubular injury, rather than being
ally, it was confirmed that CsA caused approximatelya more proximate pathogenic event. However, the time-
40% CE decrements. These data were entirely consistentcourse experiments seemingly exclude this possibility, since
with those obtained with isolated tubules, thereby sup-severe ATP depletion was observed prior to the emer-
porting the major conclusion of this study: That normalgence of tubular cell death (LDH release). The mecha-
functioning of the cholesterol/cholesterol ester cycle maynism by which disrupted cholesterol cycling might impair
be a critical determinant of tubule viability.mitochondrial ATP production remains unknown. How-
There have been several suggestions in the literatureever, that cholesterol/cholesterol ester transport into the
that CEs can exert cytoprotective effects on a variety ofmitochondrial inner membrane may be critically linked
cell types [42, 43]. In the case of tubular cells, we haveto mitochondrial function and pore transition opening
previously documented that COase-driven CE incre-[39], and that ubiquinone, a key mitochondrial electron
ments can mitigate hypoxic injury [19]. In the presenttransporter, can also be impacted by altered cholesterol
study, COase also attenuated progesterone’s cytotoxichomeostasis [40] suggest potential mechanistic links.
effect (Fig. 2). If CEs can induce protection, then a corol-Both progesterone and TFP induced extensive plasma
lary of this principle could be that impaired cholesterolmembrane disruption, as denoted by LDH release. De-
cycling/CE production during evolving cell injury mightspite the fact that each agent produced the same degree
exacerbate tubular cell death. To test this hypothesis,of ATP depletion, the mechanisms by which cell lysis
HK-2 cells were exposed to either 1 or 5 g/mL CsA inresulted were not the same. This is indicated by the fact
the presence or absence of concomitant, Fe-mediatedthat glycine and C20:4 each protected against progester-
oxidative stress. Whereas CsA caused no overt cell kill-one, but not TFP toxicity, as reflected by the LDH re-
ing, it dramatically increased Fe-mediated cell death.lease. Since mitochondrial dysfunction is oftentimes as-
The Fe challenge, by itself, was associated with a tenfold
sociated with tubular oxidative stress [41], we questioned
increase in CE accumulation, a previously documented
whether progesterone and TFP might have induced dif- consequence of in vivo or in vitro tubular damage that
fering degrees of plasma membrane lipid peroxidation, precedes lethal cell injury [20]. That CsA completely
possibly accounting for different membrane responses blocked these Fe-mediated CE increments and that in-
to glycine and C20:4 treatment. However, neither agent creased cell death resulted support the concept that CE
significantly impacted MDA levels, seemingly ruling out formation during cell injury could be an adaptive re-
this hypothesis. Another possibility that was considered sponse which helps mitigate evolving cell death. Clearly,
is that glycine might preserve ATP levels during proges- CsA can exert protean effects on cellular integrity, mak-
terone, but not TFP treatment, thereby allowing for cyto- ing it impossible to conclude that its ability to worsen Fe-
protection to occur in the former instance. However, this mediated injury was only due to CE production blockade.
was also excluded, given that glycine was protective with- However, that sublethal concentrations of progesterone
out changing tubular ATP content. A third possibility can potentiate Fe-mediated injury in isolated tubules (data
for different responses to glycine and C20:4 could be drug- not shown) provides additional support for this concept.
specific alterations in plasma membrane phospholipid It is noteworthy that CsA exacerbated HK-2 cell injury
expression evoked by TFP versus progesterone treatment. even when used in a clinically achievable concentration
However, no significant phospholipid changes were ob- (1 g/mL). This raises some intriguing clinical questions.
served with these agents, either compared to each other (1) Might an interruption of cholesterol cycling contrib-
or to control tubules. Surprisingly, there was no evidence ute to CsA’s inherent nephrotoxicity? (2) Might altered
of lysophospholipid generation during either TFP or pro- cholesterol cycling within the renal vasculature impact
gesterone treatment. This implies that progesterone- and CsA’s well-recognized vasculopathic effects? (3) Might
TFP-mediated cell lysis did not require extensive phos- such an action(s) contribute to CsA’s well known ability
pholipase A2 (PLA2)-mediated plasma membrane dam- to worsen immediate post-renal transplant ARF?
age. Given these results, the mechanisms by which P In conclusion, the results of the present study provide
experimental support for the concept that interruptionglycoprotein inhibition and the resultant ATP/CE decre-
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